Rehabilitating nicotine amidst a pandemic: Big Tobacco’s Playbook in the 21st century
By Ties Keyzer, | 19 December, 2020
A cross-border investigation uncovered how COVID-19 is used a marketing opportunity for the tobacco industry. For decades the tobacco industry casted doubts on the harms of smoking. During the COVID-19 pandemic, a network of scientists and lobbyists brought forward supposed benefits of nicotine, such as protection against the coronavirus. The Investigative Desk and Le Monde revealed that some of these scientists have direct or indirect ties with the tobacco industry.
Read the full story in Le Monde and Argos Online, or listen on Argos Radio (in Dutch).
More investigations
Goliath vs. David: The race to the EU defense money
The war in Ukraine has unveiled a new threat to Europe’s security: Russia’s deployment of hypersonic missiles. With their unparalleled speed and maneu
The Investigative Desk Newsletter special edition July 2023
Read the full newsletter here. Dear readers, In this special edition we present you two major stories we just published. An international team,
Big Tobacco’s Beyond Nicotine Strategy
The past few years, the four biggest tobacco companies (Philip Morris International/Altria, British American Tobacco, Japan Tobacco International and
Why Europe is failing to provide Ukraine with sufficient ammunition
Since the February 2022 invasion, Ukraine’s five main military partners alone (US, Germany, UK, Poland, and the Netherlands) pledged more than 60 bill
The Investigative Desk Newsletter Q2 2023
Read the full newsletter here. Dear reader, This time, we bring you two stories and a book. Our editor Tim Luimes investigated the lobbying activitie
Chemicals lobby moves full steam ahead to undermine pfas ban
Europe wants to ban all pfas at once. The chemical industry is lobbying for the exemption of fluoropolymers. These substances, a type of plastics, are
